USPTO serial 85977444
LEADERSHIP IN NANOPHARMACEUTICALS
Reviewed by CopyMark Law Group
Reg. 4243699Status 710
- Filing date
- Status date
- Registration date
- Nov 13, 2012
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LEADERSHIP IN NANOPHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Ehrlich
DAVID EHRLICH FROSS ZELNICK LEHRMAN & ZISSU, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of oncological diseases or disorders; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in the treatment of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical | SECTION 8 - CANCELLED | May 21, 2012 |
| 042 | Medical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cerulean Pharma Inc.
- Other trademarks owned by Cerulean Pharma Inc.
- Other trademarks owned by Cerulean Pharma Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named LEADERSHIP IN NANOPHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 14, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 13, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 5, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Jan 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2016 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 13, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED | — |
| Oct 9, 2012 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Oct 1, 2012 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 5, 2012 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 4, 2012 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 4, 2012 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jul 24, 2012 | IUAF | USE AMENDMENT FILED | — |
| Jul 24, 2012 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jul 24, 2012 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 24, 2012 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 7, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Mar 6, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 2, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 8, 2012 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 8, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 28, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Jul 26, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 26, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 26, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 8, 2011 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 14, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2010 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 10, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 10, 2010 | ALIE | ASSIGNED TO LIE | — |
| Oct 29, 2010 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 28, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 28, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 28, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jul 20, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 19, 2010 | NWAP | NEW APPLICATION ENTERED | — |